Alma
United States
- New York, New York
- 25/08/2022
- Series D
- $130,000,000
At Alma, we’re making it easier for consumers to access high-quality, affordable mental health care by supporting providers in building thriving private practices. We believe that when therapists have better resources, they’re able to provide better care to their clients. When a provider joins Alma, they gain access to a suite of tools that not only help them better run their business, but also grow it sustainably and develop as a provider. Our consumer experience is designed to empower people in their search for mental health care, offering multiple pathways and individualized support, if and when someone needs it. We’ve raised $90.5M from incredible investors like Insight Partners, Tusk, Primary, Optum Ventures, and First Round and were named one of Fast Company’s Most Innovative Companies in Health in 2020.
- Industry Mental Health Care
- Website https://helloalma.com/
- LinkedIn https://www.linkedin.com/company/withalma/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)